The purpose of this study was to assess peripheral quantitative computed tomography IpQCT) imaging for measurement of volumetric bone mineral density (BMD)in vivo in mouse tibia following ovariectomy, and following treatment with 17p-oestradiol(E2). Two studies were undertaken. In study I, three groups (n = 10) of mature mice were ovariectomized (OVX)or sham operated (SHAM)ione of the OVX groups was dosed weekly with E2 (OVX·E2).Images of the proximal tibia were acquired on the day of surgery and at intervals following surgery until week 6. In study 2, four groups (OVX,SHAM, OVX·E2and a SHAM group dosed with E2, SHAM·E2j of immature mice (n = 10)were imaged weekly up to 10 weeks post-surgery.
animal experiments addressing disease progression and drug efficacy (Waterton et al. 1992 , Waterton et a1. 1996 ,provided that precise and accurate quantitation of the images is achieved. Of particular interest is the use of imaging in models of musculoskeletal disorders such as arthritis and osteoporosis, since other methods for serial assessment of these diseases often have considerable limitations. For the treatment and prevention of osteoporosis, preclinical evaluation of new drugs requires noninvasive, in vivo studies of bone quality (Reginster et al. 1995) . Although no single animal model exhibits all of the features of human osteoporosis IReginster et ai. 1995) , the OVX rat has many qualitative similarities with the human disease, and has been extensively studied (Wronski et al. 1988 ). The rat model has been successfully used to demonstrate the effectiveness of antiresorptive agents such as oestrogen (Wronski et al. 1988) , as well as calcitonin and bisphosphonates such as risedronate and alendronate (Rodan et al. 1993 , Baumann &. Wronski 1995 . In addition, the OVX rat model has been used to demonstrate that parathyroid hormone has anabolic effects on bone in vivo (Baumann &. Wronski 1995 , Li et al. 1995 . A critical component of bone quality is the bone mineral density, which can be measured by pQCT. Previous studies in the rat investigated the precision of pQCT in long bones (Rosen et al. 1995 , Sato et al. 1995 , Breen et al. 1996 , Ferreti et al. 1996 , Gasser 1996 . In addition, pQCT has been used to study the efficacy of antiresorptive therapies in the rat (Sato et al. 1996 , Millest et al. 1997 .
The mouse has been less widely used than the rat to investigate the effects of hormone withdrawal on bone metabolism. However, histomorphometry has been used to quantify the response of bone in OVX mice, following chronic therapy with oestradiol. It has been shown that OVX Swiss-Webster mice lose tibial cortical bone after ovariectomy and that oestradiol treatment stimulates bone formation in both OVX and SHAM animals (Edwards et al. 1992 , Bain 1993a ). Ornoy et al. (19941,using Sabra strain mice, found that the ash weight of the tibiae was comparable in OVX and control mice, but that epiphyseal bone area was reduced by ovariectomy. These authors also showed that oestrogen treatment of SHAM and OVX mice increased both bone mass and area. Ash weight has also been used to determine BMD in mice and to assess responses to ovariectomy and therapeutic agents. Bain et al. (1993a) showed in BALB/c strain mice that oestrogen stimulated bone formation in SHAM and OVX mice as assessed by histomorphometry, but were unable to detect any effect of ovariectomy on bone ash weight. Broulik (1991), using H 8reen et al. strain mice, demonstrated that ovariectomy decreased bone density and that this could be prevented by administration of the oestrogen partial agonist tamoxifen. Although these investigations have permitted the investigation of changes in bone turnover in response to ovariectomy, histomorphometry and ash weight suffer from the disadvantage that they are terminal measures at a single timepoint and are time consuming compared to tomographic techniques such as pQCT.
X-ray techniques have not been widely used for the investigation of BMD in mice, however DEXA (Jilka et al. 1996) and pQCT (Beamer et al. 1996 , Chaki et al. 1996 , Chen et al. 1996 , Linkhart et al. 1996 have been used ex vivo to investigate variability in peak BMD between inbred strains of mice. These studies did not however use DEXA or pQCT to investigate the effects of ovariectomy. There are some advantages in extending and developing methods of tomographic assessment so that they can also be employed in murine models of bone loss and formation. Transgenic and congenitally osteoporotic models have been described in the mouse but not in the rat (Lewis et al. 1993 , Poli et al. 1994 , Pereria et al. 1995 , Erhlebacher &. Derynck 1996 , Hart et al. 1996 and these mouse models may have relevance to the study of human disease and the investigation of novel therapies. In addition, there is approximately an eight-fold difference in body weight between the species, so that for compounds of the same potency in both species, less material would be required for efficacy studies in the mouse, provided that the same statistical power in assessment can be achieved. The relatively small changes in bone quality and density reported in the studies on OVX mice make the model a demanding test of the power of the pQCT technology. We report here an evaluation of the power of pQCT for chronic non-invasive measurement of BMD and for the assessment of the effects of oestrogen on BMD in the proximal tibia of mature and immature OVX mice. The usefulness of the proximal tibia as a sensitive indicator of bone loss has been demonstrated previously, and hence in this study this region was chosen as an early indicator of bone loss (Breen et a1. 1995 , Sato et a1. 1995 . The aims of the study were to determine the precision of the pQCT technique and to determine whether it could be used to investigate antiresorptive or boneforming therapies in the mouse.
Materials and methods

Animals and husbandry
Female Alderley Park (Alpk:APfCD-l) strain mice were used. Mice were housed in an open system in groups of five, in polycarbonate cages 367 x 207 x 104mm (Techniplast), with free access to food (PCD 3/8 SDF pelleted chow) and filtered water, on a 12-h light/dark cycle. Humidity was 60-67% and temperature maintained at 21°C minimum, 22°C maximum, with 25-30 changes of filtered air per hour. Bedding was autoclaved 5/8 mesh dust-free shavings. Animals were conditioned to this environment for two weeks prior to surgery.
Study 1: BMD measurements and effects of oestradiol in mature mice
The first study aimed to investigate the power of pQCT for the non-invasive measurement of BMD in mature mice [14 weeks old on the day of surgery). Three groups of 10 mice were anaesthetized with halothane ('Fluothane', Zeneca Pharmaceuticals, Macclesfield, Cheshire, UK), and were either ovariectomized bilaterally, via a dorsal approach (OVX) or sham-operated (ovaries externalized and then replaced) (SHAM). Commencing the day after surgery, one group of ovariectomized mice (OVX·E2) received once weekly treatment with 17p-oestradiol benzoate [E2, 150 jtg/kg s.c.), and the remaining animals received vehicle once weekly (0.3 ml arachis oil s.c.) for 6 weeks. The tibia of each of the animals was imaged on the day of surgery and at intervals following surgery. At the end of the study, the mice were humanely killed and an abdominal necropsy performed to determine the success of the surgery.
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Study 2: BMD measurements and effects of oestradiol in immature mice A second study was undertaken in skeletally immature mice (6 weeks old on the day of surgery). The experimental design was as described in study I, with the following exceptions. Four groups of animals were studied: OVX, SHAM and OVX·E2, plus a SHAM group which was dosed with E2 (SHAM·E2). Three weeks post-surgery, dosing of E2 was stopped. Three of the mice from each of the E2-treated groups were humanely killed and radiographs acquired. The remaining mice continued on the study (without being dosed) but were only imaged again once, on the final day of the study. The study was terminated 10 weeks following surgery.
Imaging
Computed tomography was carried out using an 'XCT960A' pQCT bone densitometer [Stratec, Birkenfeld, Germanyl. This is a second generation multiple-detector rotatetranslate X-ray computed tomography device, employing five detectors (with 2.5°separation) and 15 detector positions, a 120 mm diameter gantry, and a 1mm, 18 keY fan beam. It is a slightly modified version of the clinical 'XCT960' instrument, with higher resolution to accommodate rodents. The instrument was calibrated weekly via a COMAC (European Union Concerted Action Committee for Biomedical Engineering) semi-anthropomorphic hydroxyapatite phantom (Schneider 1995) . A cradle for mouse studies was constructed in this laboratory. The cradle has a semicircular cross-section (35 mm diameter), can be positioned in the axial direction with better than 0.5 mm precision, and can be levelled and centred. This apparatus was designed for use with the tibia, which was of interest in these studies, and is less practicable for longitudinal high-resolution studies of the femur. Animals were anaesthetized with halothane, and placed in the supine position in the cradle with the ipsilateral knee joint placed above the detectors. The contralateral leg was positioned out of the scan plane. A low-resolution scout scan of the limb was obtained.
This contained very little anatomical detail but was sufficient to allow identification of the joint space. The condyles were then used as a reference line to allow accurate positioning of further slices. Multiple slice transverse image sets were obtained 5 mm from the reference line using a slice separation and width of 1.0 mm. From these image sets the data from the three most rostral ima~es which included the tibia were used. The smallest possible voxel size was chosen. For this equipment the size is limited to 0.148 x 0.148 xl mm. The choice of resolution is limited by the circumference of the measured object as the calibration requires that the surrounding air must be included in the scan area. 'Special Analysis Software version 5.1' (Stratec) was used to draw in each transverse slice, a region of interest around the entire tibia, excluding the fibula. Total cortical and trabecular bone mineral densi~y (BMD, mg/cm 3 ) were calculated for the tibia in each slice and for each of these parameters, the mean of the values for the three slices was taken. Except when otherwise stated, each BMD measurement represents the mean for all slices imaged. A standardized analysis (peel mode 2, cort mode I, contour mode 2, threshold 0.7 g/cm 3 ) was applied to the images. In this analysis, low-attenuation «0.4 g/cm 3 1 voxels outside the bone (i.e. soft tissue) were discarded by the contour mode algorithm. The remaining voxels (defined as 'total') were then further segmented between 'cortical' (defined as exceeding the threshold), and 'trabecular' (not exceeding the threshold).
Radiographs
At week 3 of study 2, whole body radiographs of six mice, three from the SHAM·E2 group and three from the OVX·E2 group were acquired post-mortem and compared to agematched controls. The images were acquired on conventional X-ray equipment with a ceiling mounted X-ray tube. A min-R screenfilm system was used, with the following parameters; focal spot 0.1 mm, tube voltage 41 kv, tube current 50 mA, and exposure time O.4s. Breen et al. 
Precision and accuracy
The test-retest coefficient of variation (CV)in vivo was examined in the proximal tibia in each mouse. Four animals (two SHAM, two OVX) were imaged by two observers (SAB, BEL).Both observers made 10 measurements each, in one OVX and one SHAM animal. The animal was removed from its cradle, and the joint-space position and reference line re-determined for each measurement. CVs reported for each observer are the root mean square (RMSI CV for the two separate experiments. To assess the contribution of partial volume effects to the measurement of BMD, images were acquired at two different resolutions. Eight excised limbs were imaged using the resolution applied in vivo in this study (0.148 mm), and then at a higher resolution (0.092 mm), at the same location in the proximal tibia. Correlations between BMD values in corresponding slices were calculated by linear regression and mean deviations are given.
Statistical analysis
Data are expressed as mean ± SEM and statistical differences between groups were calculated using Student's t-test (except where otherwise stated): a P value of <0.05 was considered significant. The change in BMD in individual animals was calculated for each animal, by subtracting the BMD measured on the day of surgery from subsequent measurements. The statistical power calculations are for the one-sided Student's t-test, and give the sample sizes needed for: a (probability of Type I error) = fJ (probability of Type II error) = 0.05 for a test of the hypothesis that fl, the mean BMD in untreated OVX animals, is equal to flo, the mean BMD in untreated OVX animals, assuming equal standard deviations, (J.
Results
Precision and accuracy
A typical image of a transverse slice through the proximal tibia is shown in Fig 1. Trabecular and cortical bone are resolved and typically 60 pixels in the trabecular region Test-retest CV: each observer made 10 measurements on two mice with repositionin9 between each measurement. Two factor analysis of variance found no significant difference between the two observers. Comparison at two different resolutions: systematic errors from partial volume averaging between different bone compartments were assessedby re-measuring BMD at 2.G-fold smaller voxel volume. Because multislice measurements were made in individual animals, and hence are not independent, it is not appropriate to perform significance testing on the correlation coefficients.
CV= coefficient of variance, BMD = bone mineral density and 80 pixels in the cortical compartment were measured. This corresponds to a diameter for the trabecular compartment of about 9 pixels, and a cortical thickness of about 5 pixels. A simplistic concentriccylinder model would imply that about 13% of these trabecular compartment voxels, and more than half the cortical voxels, lie in the boundary layer of their respective compartments and therefore must suffer partial volume averaging. Assessments of precision and partial volume averaging in the BMD measurements are given in Table 1 . Partial volume averaging was assessed in measurements made at different resolutions. Total BMD measurements were, as expected, highly correlated, as were cortical BMD measurements, however there was considerable variation between the trabecular BMD measurements made at the two resolutions. Cortical BMD appeared to be systematically underestimated at the coarser resolution employed in vivo. The overall precision for total BMD, acquired from the 40 multislice measurements was 2.4%. In the analysis of studies 1 and 2 we chose to use only the total BMD parameter, because this parameter showed better reproducibility than trabecular BMD, while cortical BMD results implied some systematic error.
Study 1
Mature E2-treatep OVX animals showed a rapid increase in total BMD, while the changes in the SHAM and untreated OVX groups were small (Figs 2 and 3) . Group analysis of total BMD measurements (Fig 2) , showed a lower total BMD in the OVX group at each of the timepoints sampled, but the difference between SHAM and OVX groups was never statistically significant. The increase in total BMD in the E2-treated group was first detected 2 weeks post-OVX (P<O.OOl), reached a maximum 4 weeks post-OVX (P<O.OOl), and was maintained until the end of the study. Analysis of total BMD changes in individual animals (subtracting the total BMD measurement on the day of Week Post-Surgery .c U BMD measurements in immature mice E2-treated OVX and SHAM animals showed a rapid increase in total BMD while the changes in the untreated animals were small (Figs 4 and 5) . Group analysis of total BMD measurements (Fig 4) , revealed no significant difference between the untreated OVX and SHAM group. A significant increase in total BMD in the SHAM·E2 (P = 0.006) and OVX·E2 (P = 0.04) treated groups, was evident one week post-surgery. Assessment of total BMD in individual animals ( Fig 5) demonstrated a small but sustained increase over the course of the study in both untreated groups: the SHAM group increased total BMD significantly faster than the OVX group from 3 weeks post-surgery (P = 0.021, until week 10 (P = 0.02). The E2-treated animals were imaged at week 10, and no loss of total BMD was detected from the value achieved at the cessation of dosing on week 3. Trabecular BMD was 259 mg/cm 3 at the outset of the study and increased rapidly in the OVX·E2 and SHAM·E2 group, reaching 352 and 340 mg/cm 3 respectively by week 3. Two weeks after surgery the increase was +64 ± 6 mg/cm 3 in the OVX·E2 group: this was significantly different [P<O.OOl, paired ttest) from the OVX group where the change in trabecular BMD was +5±4mg/cm 3 . surgery from subsequent measurements (Fig  3) , showed a small but significant increase in the SHAM group, during the course of the experiment (P<0.05), while the OVX group exhibited no change. An increase in the OVX·E2-treated animals was detected (P = 0.03), as early as one week post-surgery, using each animal as its own control. Trabecular BMD was 281 mg/cm 3 at the outset of the study and increased rapidly in the OVX·E2 group, reaching 336 mg/cm 3 by week 4. Two weeks after surgery the increase was +15 ±3 mg/cm 3 in the OVX·E2 group: this was significantly different (P<O.OOI, paired t-test) from the OVX group where the change in trabecular BMD was -9 ± 5 mg/cm 3 . Cortical BMD results are not presented because we expect them to suffer partial volume averaging.
Other findings
Radiographs provided qualitative confirmation of the pQCT findings from the immature mouse study. The tibia and femora of the E2dosed animals were clearly osteopetrotic at week 4, when compared to age-matched animals (Fig 6) . The initial body weight, measured on the day of surgery, and the final body weights for studies 1 and 2 are given in Table 2 . Although the E2-treated groups tended to have higher body weights than the OVX and SHAM groups at the end of the study, there was no significant difference between the groups in either of the studies.
Using these data, it is possible to estimate the power of the pQCT technique to detect the effects of experimental therapies. Some representative values are given in Table 3 .
Discussion
Because animal studies must be performed to evaluate novel compounds for the treatment of bone loss, a clinical imaging technique such as DEXA or pQCT must be adapted for measurement of BMD changes in experi-mental animals. pQCT has the potential advantage that, as a tomographic technique, the trabecular compartment can be separately resolved. We previously applied pQCT to study bone loss in the rat (Breen et a1. 1996) ,and we report here the evaluation of the technique for longitudinal measurements of BMD in vivo in the mouse. The precision of our total BMD measurement ICV 2.4%), is not as good as the corresponding figure obtained ICV 1.5%) in rat long bones (Breen et a1. 1996Lor the figure of 1.2% from measurements of mouse femur acquired ex vivo IBeamer et a1. 1996) . This is probably due to a diminished anatomical resolution used in the present studies. Clearly in such small animals, anatomical resolution is likely to be important in achieving high precision, Week Post-Surgery and (J are estimated from this work or from Breen et al. (1996) because low-resolution measurements will likely suffer partial-volume averaging. However, this work shows that pQCT, with a Noxel volume of 0.02.ul, provides measurements with sufficient power to permit assessment of disease model progression and drug efficacy (Table 3) . Partial volume averaging was investigated by measurements at different resolutions and showed that total BMD was independent of resolution in the range employed, correlating well with measurements obtained at higher resolution. However, studies of cortical BMD provided measurements which differed with the two voxel volumes employed. We conclude that the algorithm employed in this study may be inadequate for assessment of cortical BMD in mouse long bones in vivo. It might be possible to devise an algorithm to exclude endosteal and periosteal voxels from the cortex, in order to avoid partial volume averaging, but that was not attempted in this study. Alternatively, higher resolution instruments (Kinney et a1. 19951may be preferred if the cortical compartment is of interest. Our aim in this study was to exploit the pQCT technique in longitudinal studies, focussing on precision. A weekly calibration with a standard phantom was undertaken to ensure accuracy, but independent measurements of accuracy were not specifically made. In the human (using the XCT960 instrumentl, correlation coefficients of 0.86 to 0.95 have been reported between regional pQCT and regional chemical or ash analysis (Louis et a1. 1996, Takada et a1. 1996). Group analysis was unable to detect a significant difference between OVX and SHAM animals in either of the studies. The large increase in BMD in E2-treated mice was readily detected by group analysis as early as 2 weeks, following treatment with pharmacological doses of E2. The osteopetrosis evident in the E2-treated groups are in agreement with other studies, and are believed to be due to increased rates of bone formation on both the endosteal and cancellous bone surfaces (Edwards et a1. 1992 , Bain et a1. 1993b . This technique therefore, may provide a relatively simple method to assess potential bone forming agents in a murine model.
pQCT is a non-invasive modality, so multiple examinations on a single mouse were possible, with each animal acting as its own control. Mature mice in the OVX group did not lose bone through the course of the experiment, while the SHAM animals showed a small increase in BMD. Immature OVX mice, however, tended to increase their BMD, reaching a plateau as they matured. Changes in bone mineral density measured in vivo reflect a balance between formation and resorption. These pQCT studies showed that, although no animal lost bone overall, the OVX groups showed a shift away from formation and the E2 groups showed a shift towards formation. Studies which employ only terminal, single-time-point measurements, such as ashing or histomorphometry, to compare SHAM and OVX groups, cannot distinguish 'bone loss' from 'slower bone formation', even though the former term is often used. It is gratifying to note, that, although there were relatively small changes in BMD in individual animals, it was possible to detect these changes by pQCT. As with the group analysis, osteopetrosis in the E2treated groups was readily detected.
Quantitative X-ray techniques like pQCT and DEXAare ideally suited to the assessment of bone resorption and formation, because of their sensitivity and specificity for changes in calcium levels. No other imaging modality offers equivalent information in vivo. Radioisotope imaging methods offer pixel resolution at best 2-lOmm. Ultrasound has application in the study of human osteoporosis, but has not to our knowledge been applied in mouse bones, and might be expected to pose difficulties in such small structures if adequate coupling between the probe and the tissue cannot be obtained. High-resolution MRI has not to our knowledge been applied to assessment of trabecular structure in the mouse in vivo: in any case it does not detect the cortical and trabecular bone mineral, but the water and fat surrounding them. MRI has been applied to the assessment of trabecular quality in humans and rats in vivo via measurement of the effective transverse relaxation time T5. (Checkley et al. 1996) ,however this parameter is likely to be less sensitive to trabecular structure at the higher resolution required in the mouse.
Typically 17-40% bone loss in the tibia has been observed in OVX rat studies (Rosen et al. 1995 , Sato et al. 1995 , Breen et al. 1996 Group differences are easily detected in the rat by pQCT, using small group sizes, as BMD measurements have a precision of 1-2%. pQCT is therefore a sensitive means of measuring bone loss and gain in rats (Table  3 ). The rapid bone loss and obesity evident in the rat did not occur in the OVX Alderley Park strain mouse used in these studies. This indicates that there may be both species and 475 strain differences in the response to ovariectomy as suggested by the findings of other studies which have also shown that ovariectomy did not cause a decrease in bone mass in Sabra (Omoy et al. 1994) or BALB/c strain mice (Bain 1993a ). These strain differences should be considered when investigating novel antiresorptive agents in the mouse. However, despite the small difference in the mouse in BMD between SHAM and OVX groups, analysis of individual animals did prove adequate to detect differences between these groups. The technique also proved more than adequate in the detection of the anabolic effects of oestradiol suggesting that the mouse may be a suitable species for investigating novel bone-forming agents.
